Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2.

× No keyword cloud information.

2 in total

1. Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study.

Authors: Rositsa G Koleva-Kolarova; Marcel J W Greuter; Talitha L Feenstra; Karin M Vermeulen; Erik F J de Vries; David Parkin; Erik Buskens; Geertruida H de Bock
Journal: Oncotarget Date: 2018-04-13

2. Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell lines.

Authors: Hai Cui; Ying Cheng; Su-Zhou Piao; Yun-Jie Xu; Hong-Hua Sun; Xian Cui; Xiang-Zi Li; Song-Nan Zhang; Long-Zhen Piao; Yong-Min Jin; Zhen-Hua Lin; Xiong-Hu Shen
Journal: Cancer Cell Int Date: 2014-01-29 Impact factor: 5.722

2 in total